Company intelligence / Profile preview

PrECOG

Philadelphia, Pennsylvania, United Statesprecogllc.org ↗

Ownership: Private
Development stage: Phase 2

Overview

PrECOG leads and sponsors multi-center clinical trials focused on advancing new treatments for cancer. Their work includes early-phase biomarker-driven studies through to pivotal registration trials. They have demonstrated expertise in immuno-oncology, including the evaluation of novel agents like pelareorep with checkpoint inhibitors in metastatic breast cancer. Results from their sponsored or managed trials are published to advance knowledge of effective therapies for patients with various cancers.

Therapeutic areas: Oncology
Modalities: Immuno-oncolytic virus therapy (via collaborations)Immunotherapy (via clinical trials and partnerships)Small molecule and biologic therapies may be included in broader portfolio but not explicitly listed in sources.
Industry: Contract Research Organization

Partnerships

Oncolytics Biotech Inc. – collaboration on BRACELET‑1 study evaluating pelareorep plus checkpoint inhibitor therapy in metastatic breast cancer.Multiple academic medical centers via ECOG‑ACRIN network.

Beyond the preview

Go deeper on PrECOG.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on PrECOG.

Explore the full profile